Adage Capital Partners Gp, L.L.C. Karyopharm Therapeutics Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

$54.6 Billion
Q3 2024

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 4,319,842 shares of KPTI stock, worth $2.89 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,319,842

Previous 4,319,842 -0.0%

Holding current value

$2.89 Million

Previous $3.76 Million 4.6%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.87 - $1.58 $713,262 - $1.3 Million	819,842 Added 23.42%	4,319,842 $3.76 Million
Q1 2024 May 15, 2024	BUY	$0.72 - $1.66 $1.32 Million - $3.05 Million	1,836,700 Added 110.43%	3,500,000 $5.29 Million
Q4 2023 Feb 14, 2024	BUY	$0.68 - $1.31 $1.13 Million - $2.18 Million	1,663,300 New	1,663,300 $1.43 Million
Q4 2022 Feb 14, 2023	BUY	$2.48 - $5.93 $1.91 Million - $4.57 Million	770,713 New	770,713 $2.62 Million
Q2 2021 Aug 16, 2021	SELL	$8.11 - $11.11 $10.9 Million - $15 Million	-1,349,800 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$9.85 - $17.69 $11 Million - $19.7 Million	-1,115,200 Reduced 45.24%	1,349,800 $14.2 Million
Q4 2020 Feb 16, 2021	SELL	$14.15 - $17.19 $10.6 Million - $12.9 Million	-747,931 Reduced 23.28%	2,465,000 $38.2 Million
Q3 2020 Nov 16, 2020	SELL	$14.14 - $19.71 $506,325 - $705,775	-35,808 Reduced 1.1%	3,212,931 $46.9 Million
Q2 2020 Aug 14, 2020	SELL	$16.6 - $25.25 $7.88 Million - $12 Million	-474,793 Reduced 12.75%	3,248,739 $61.5 Million
Q1 2020 May 15, 2020	SELL	$14.38 - $27.72 $912,669 - $1.76 Million	-63,468 Reduced 1.68%	3,723,532 $71.5 Million
Q4 2019 Feb 14, 2020	BUY	$9.23 - $19.67 $19.3 Million - $41.1 Million	2,087,000 Added 122.76%	3,787,000 $72.6 Million
Q3 2019 Nov 14, 2019	BUY	$5.66 - $11.85 $9.62 Million - $20.1 Million	1,700,000 New	1,700,000 $16.4 Million

Others Institutions Holding KPTI

# of Institutions

Shares Held

57.6M

Call Options Held

258K

Put Options Held

81.2K

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $53.5M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Karyopharm Therapeutics Inc. Transaction History